YETI Holdings, Inc.NYSE: YETI

Third Quarter 2026 Supplemental Information

· Issued by YETI Holdings, Inc.

Summary by 6ix AI

Beginning in the third quarter of 2026, YETI excludes product recall reserve adjustments related to its 2023 voluntary recalls from its non-GAAP measures (results adjusted away from standard accounting rules), and has recast non-GAAP results for the fourth quarter and fiscal year 2025 and the first and second quarters of 2026. Previously reported GAAP results are not affected.

Key details

  • Recast adjusted net income per diluted share: fourth quarter 2025 rises from $0.92 to $0.95, and fiscal 2025 from $2.48 to $2.51.
  • Recast adjusted net income per diluted share for 2026: second quarter rises from $0.67 to $0.70, and the year to date through the second quarter from $0.92 to $0.96. The first quarter stays at $0.26.
  • The change reverses the approach YETI adopted with its fourth quarter 2025 results and matches the treatment it used from fiscal 2022 through fiscal 2024. YETI says the new presentation better reflects its underlying operating performance.
  • In the second quarter of 2026, YETI concluded that recovery of tariffs under the International Emergency Economic Powers Act was probable. It recorded a total net benefit of $45.6 million: a $42.6 million reduction of cost of goods sold and $2.9 million of interest income. Its non-GAAP results exclude $34.4 million related to the 2025 net tariff impact and the $2.9 million of interest income.

6ix AI wrote this summary from the release below and checked it against the release.

‌Beginning in the third quarter of 2026, product recall reserve adjustments related to our 2023 voluntary recalls are excluded from non-GAAP financial measures. This represents a change from the approach we adopted with our fourth quarter of 2025 results, under which we did not exclude product recall reserve adjustments from our non-GAAP results, but is consistent with the treatment we applied from fiscal 2022 through fiscal 2024. We believe this presentation better reflects our underlying operating performance and improves comparability across periods. Our non-GAAP results for the nine months ended October 3, 2026 exclude product recall reserve adjustments recorded in the first and second quarters of 2026, which were included in our previously reported non-GAAP results for those periods. As a result, the non-GAAP results for the fourth quarter and fiscal year 2025 and the first and second quarters of 2026 have been recast to conform to the current definition. These updates do not affect our previously reported GAAP results.

As Reported

As Recast

Q1'26

Q2'26

YTD Q2'26

Q1'26

Q2'26

YTD Q2'26

Net sales

$ 380,414

$ 483,868

$ 864,282

$ 380,414

$ 483,868

$ 864,282

Product recall(1)

-

-

-

300

1,530

1,830

Adjusted net sales

$ 380,414

$ 483,868

$ 864,282

$ 380,714

$ 485,398

$ 866,112

Gross profit

$ 210,211

$ 322,524

$ 532,735

$ 210,211

$ 322,524

$ 532,735

Product recall(1)

-

-

-

300

2,036

2,336

IEEPA tariff refunds(2)

-

(34,433)

(34,433)

-

(34,433)

(34,433)

Adjusted gross profit

$ 210,211

$ 288,091

$ 498,302

$ 210,511

$ 290,127

$ 500,638

Selling, general, and administrative expenses

$ 197,773

$ 229,006

$ 426,779

$ 197,773

$ 229,006

$ 426,779

Non-cash stock-based compensation expense

(9,401)

(8,907)

(18,308)

(9,401)

(8,907)

(18,308)

Long-lived asset impairment

(973)

-

(973)

(973)

-

(973)

Product recall(1)

-

-

-

(176)

(749)

(925)

Organizational realignment costs(3)

(764)

-

(764)

(764)

-

(764)

Stockholder matters(4)

(1,700)

(74)

(1,774)

(1,700)

(74)

(1,774)

Executive transition costs(5)

(599)

-

(599)

(599)

-

(599)

Technology transformation costs(6)

(758)

(174)

(932)

(758)

(174)

(932)

Adjusted selling, general, and administrative expenses

$ 183,578

$ 219,851

$ 403,429

$ 183,402

$ 219,102

$ 402,504

Gross margin

55.3 %

66.7 %

61.6 %

55.3 %

66.7 %

61.6 %

Adjusted gross margin

55.3 %

59.5 %

57.7 %

55.3 %

59.8 %

57.8 %

SG&A expenses as a % of net sales

52.0 %

47.3 %

49.4 %

52.0 %

47.3 %

49.4 %

Adjusted SG&A expenses as a % of adjusted net sales

48.3 %

45.4 %

46.7 %

48.2 %

45.1 %

46.5 %

As Reported

As Recast

Q1'26

Q2'26

YTD Q2'26

Q1'26

Q2'26

YTD Q2'26

Operating income

$ 12,438

$ 93,518

$ 105,956

$ 12,438

$ 93,518

$ 105,956

Non-cash stock-based compensation expense(7)

9,401

8,907

18,308

9,401

8,907

18,308

Long-lived asset impairment(7)

973

-

973

973

-

973

Product recalls(1)

-

-

-

476

2,785

3,261

Organizational realignment costs(3)(7)

764

-

764

764

-

764

Stockholder matters(4)(7)

1,700

74

1,774

1,700

74

1,774

Executive transition costs(5)(7)

599

-

599

599

-

599

Technology transformation costs(6)(7)

758

174

932

758

174

932

IEEPA tariff refunds(2)(7)

-

(34,433)

(34,433)

-

(34,433)

(34,433)

Adjusted operating income

$ 26,633

$ 68,240

$ 94,873

$ 27,109

$ 71,025

$ 98,134

Net income

$ 9,851

$ 71,317

$ 81,168

$ 9,851

$ 71,317

$ 81,168

Non-cash stock-based compensation expense(7)

9,401

8,907

18,308

9,401

8,907

18,308

Long-lived asset impairment(7)

973

-

973

973

-

973

Product recalls(1)

-

-

-

476

2,785

3,261

Organizational realignment costs(3)(7)

764

-

764

764

-

764

Stockholder matters(4)(7)

1,700

74

1,774

1,700

74

1,774

Executive transition costs(5)(7)

599

-

599

599

-

599

Technology transformation costs(6)(7)

758

174

932

758

174

932

IEEPA tariff refunds(2)(7)

-

(37,371)

(37,371)

-

(37,371)

(37,371)

Other (income) expense, net(8)

(979)

889

(90)

(979)

889

(90)

Tax impact of adjusting items(9)

(3,238)

6,695

3,457

(3,355)

6,013

2,658

Adjusted net income

$ 19,829

$ 50,685

$ 70,514

$ 20,188

$ 52,788

$ 72,976

Operating income as a % of net sales

3.3 %

19.3 %

12.3 %

3.3 %

19.3 %

12.3 %

Adjusted operating income as a % of adjusted net sales

7.0 %

14.1 %

11.0 %

7.1 %

14.6 %

11.3 %

Net income as a % of net sales

2.6 %

14.7 %

9.4 %

2.6 %

14.7 %

9.4 %

Adjusted net income as a % of adjusted net sales

5.2 %

10.5 %

8.2 %

5.3 %

10.9 %

8.4 %

Net income per diluted share

$ 0.13

$ 0.94

$ 1.06

$ 0.13

$ 0.94

$ 1.06

Adjusted net income per diluted share

$ 0.26

$ 0.67

$ 0.92

$ 0.26

$ 0.70

$ 0.96

Weighted average common shares outstanding - diluted

76,747

75,782

76,265

76,747

75,782

76,265

‌As Reported

As Recast

Q1'25

Q2'25

Q3'25

Q4'25

FY25

Q1'25

Q2'25

Q3'25

Q4'25

FY25

Net sales

$ 351,128

$ 445,892

$ 487,766

$ 583,708

$1,868,494

$ 351,128

$ 445,892

$ 487,766

$ 583,708

$1,868,494

Product recall(1)

-

-

-

-

-

-

-

-

2,275

2,275

Adjusted net sales

$ 351,128

$ 445,892

$ 487,766

$ 583,708

$1,868,494

$ 351,128

$ 445,892

$ 487,766

$ 585,983

$1,870,769

Gross profit

$ 201,722

$ 257,569

$ 272,522

$ 340,871

$1,072,684

$ 201,722

$ 257,569

$ 272,522

$ 340,871

$1,072,684

Product recall(1)

-

-

-

-

-

-

-

-

2,364

2,364

Transition costs(10)

(395)

-

-

-

(395)

(395)

-

-

-

(395)

Adjusted gross profit

$ 201,327

$ 257,569

$ 272,522

$ 340,871

$1,072,289

$ 201,327

$ 257,569

$ 272,522

$ 343,235

$1,074,653

Selling, general, and administrative expenses

$ 180,051

$ 195,545

$ 218,169

$ 265,362

$ 859,127

$ 180,051

$ 195,545

$ 218,169

$ 265,362

$ 859,127

Non-cash stock-based compensation expense

(10,144)

(11,173)

(11,093)

(15,278)

(47,688)

(10,144)

(11,173)

(11,093)

(15,278)

(47,688)

Long-lived asset impairment

-

-

(1,194)

(2,601)

(3,795)

-

-

(1,194)

(2,601)

(3,795)

Product recall(1)

-

-

-

-

-

-

-

-

(536)

(536)

Organizational realignment costs(3)

(994)

-

-

-

(994)

(994)

-

-

-

(994)

Stockholder matters(4)

(2,760)

-

-

-

(2,760)

(2,760)

-

-

-

(2,760)

Technology transformation costs(6)

-

-

-

(1,298)

(1,298)

-

-

-

(1,298)

(1,298)

Adjusted selling, general, and administrative expenses

$ 166,153

$ 184,372

$ 205,882

$ 246,185

$ 802,592

$ 166,153

$ 184,372

$ 205,882

$ 245,649

$ 802,056

Gross margin

57.4 %

57.8 %

55.9 %

58.4 %

57.4 %

57.4 %

57.8 %

55.9 %

58.4 %

57.4 %

Adjusted gross margin

57.3 %

57.8 %

55.9 %

58.4 %

57.4 %

57.3 %

57.8 %

55.9 %

58.6 %

57.4 %

SG&A expenses as a % of net sales

51.3 %

43.9 %

44.7 %

45.5 %

46.0 %

51.3 %

43.9 %

44.7 %

45.5 %

46.0 %

Adjusted SG&A expenses as a % of adjusted net sales

47.3 %

41.3 %

42.2 %

42.2 %

43.0 %

47.3 %

41.3 %

42.2 %

41.9 %

42.9 %

As Reported

As Recast

Q1'25

Q2'25

Q3'25

Q4'25

FY25

Q1'25

Q2'25

Q3'25

Q4'25

FY25

Operating income

$ 21,671

$ 62,024

$ 54,353

$ 75,509

$ 213,557

$ 21,671

$ 62,024

$ 54,353

$ 75,509

$ 213,557

Non-cash stock-based compensation expense(7)

10,144

11,173

11,093

15,278

47,688

10,144

11,173

11,093

15,278

47,688

Long-lived asset impairment(7)

-

-

1,194

2,601

3,795

-

-

1,194

2,601

3,795

Product recalls(1)

-

-

-

-

-

-

-

-

2,900

2,900

Organizational realignment costs(3)(7)

994

-

-

-

994

994

-

-

-

994

Transition costs(10)

(395)

-

-

-

(395)

(395)

-

-

-

(395)

Stockholder matters(4)(7)

2,760

-

-

-

2,760

2,760

-

-

-

2,760

Executive transition costs(5)(7)

-

-

-

-

-

-

-

-

-

-

Technology transformation costs(6)(7)

-

-

-

1,298

1,298

-

-

-

1,298

1,298

Adjusted operating income

$ 35,174

$ 73,197

$ 66,640

$ 94,686

$ 269,697

$ 35,174

$ 73,197

$ 66,640

$ 97,586

$ 272,597

Net income

$ 16,609

$ 51,151

$ 39,400

$ 58,227

$ 165,387

$ 16,609

$ 51,151

$ 39,400

$ 58,227

$ 165,387

Non-cash stock-based compensation expense(7)

10,144

11,173

11,093

15,278

47,688

10,144

11,173

11,093

15,278

47,688

Long-lived asset impairment(7)

-

-

1,194

2,601

3,795

-

-

1,194

2,601

3,795

Product recalls(1)

-

-

-

-

-

-

-

-

2,900

2,900

Organizational realignment costs(3)(7)

994

-

-

-

994

994

-

-

-

994

Transition costs(10)(7)

(395)

-

-

-

(395)

(395)

-

-

-

(395)

Stockholder matters(4)(7)

2,760

-

-

-

2,760

2,760

-

-

-

2,760

Technology transformation costs(6)(7)

-

-

-

1,298

1,298

-

-

-

1,298

1,298

Other (income) expense, net(8)

(1,376)

(5,773)

1,198

(1,216)

(7,167)

(1,376)

(5,773)

1,198

(1,216)

(7,167)

Tax impact of adjusting items(9)

(2,971)

(1,323)

(3,304)

(4,400)

(11,998)

(2,971)

(1,323)

(3,304)

(5,111)

(12,709)

Adjusted net income

$ 25,765

$ 55,228

$ 49,581

$ 71,788

$ 202,362

$ 25,765

$ 55,228

$ 49,581

$ 73,977

$ 204,551

Operating income as a % of net sales

6.2 %

13.9 %

11.1 %

12.9 %

11.4 %

6.2 %

13.9 %

11.1 %

12.9 %

11.4 %

Adjusted operating income as a % of adjusted net sales

10.0 %

16.4 %

13.7 %

16.2 %

14.4 %

10.0 %

16.4 %

13.7 %

16.7 %

14.6 %

Net income as a % of net sales

4.7 %

11.5 %

8.1 %

10.0 %

8.9 %

4.7 %

11.5 %

8.1 %

10.0 %

8.9 %

Adjusted net income as a % of adjusted net sales

7.3 %

12.4 %

10.2 %

12.3 %

10.8 %

7.3 %

12.4 %

10.2 %

12.6 %

10.9 %

Net income per diluted share

$ 0.20

$ 0.61

$ 0.48

$ 0.74

$ 2.03

$ 0.20

$ 0.61

$ 0.48

$ 0.74

$ 2.03

Adjusted net income per diluted share

$ 0.31

$ 0.66

$ 0.61

$ 0.92

$ 2.48

$ 0.31

$ 0.66

$ 0.61

$ 0.95

$ 2.51

Weighted average common shares outstanding -diluted

83,543

83,463

81,429

78,233

81,595

83,543

83,463

81,429

78,233

81,595

  1. Represents adjustments and charges associated with our 2023 product recalls.

  2. During the second quarter of 2026, we concluded that recovery of tariffs under the International Emergency Economic Powers Act ("IEEPA") was probable. The total net benefit of the IEEPA tariff refund was $45.6 million for the second quarter of 2026, consisting of a $42.6 million net benefit recognized as a reduction of cost of goods sold and $2.9 million of interest income. Of this amount, our non-GAAP results exclude $34.4 million related to the 2025 net tariff impact and $2.9 million of interest income.

  3. Represents employee severance costs in connection with strategic organizational realignments.

  4. Represents advisory and legal fees related to a stockholder matter that resulted in a cooperation agreement signed in March 2025 and its subsequent expiration in 2026.

  5. Represents severance costs related to the departure of our former Chief Financial Officer.

  6. Represents third-party consulting fees related to certain initiatives to optimize and enhance our technology infrastructure. These expenses represent non-recurring incremental costs above the normal ongoing level of spending on technology to support operations.

  7. These costs are reported in SG&A expenses.

  8. Other (income) expense, net substantially consists of realized and unrealized foreign currency gains and losses on intercompany balances that arise in the ordinary course of business.

  9. Represents the tax impact of adjustments calculated at an expected statutory tax rate of 24.5%.

  10. Represents a favorable true-up of estimated disposal costs in connection with the acquisition of Mystery Ranch, LLC.

The recast of disaggregated adjusted net sales only covers channels, categories, and geographies affected by the recall reserve adjustments. Such other channels, categories, and geographies not shown here remain accurate as previously reported.

As Reported

As Recast

Q1'26

Q2'26

YTD Q2'26

Q1'26

Q2'26

YTD Q2'26

Net sales

$ 380,414

$ 483,868

$ 864,282

$ 380,414

$ 483,868

$ 864,282

Product recall(1)

-

-

-

300

1,530

1,830

Adjusted net sales

$ 380,414

$ 483,868

$ 864,282

$ 380,714

$ 485,398

$ 866,112

Direct-to-consumer net sales

$ 196,819

$ 265,873

$ 462,692

$ 196,819

$ 265,873

$ 462,692

Product recall(1)

-

-

-

300

1,530

1,830

Direct-to-consumer adjusted net sales

$ 196,819

$ 265,873

$ 462,692

$ 197,119

$ 267,403

$ 464,522

Coolers & Equipment net sales

$ 156,101

$ 232,404

$ 388,505

$ 156,101

$ 232,404

$ 388,505

Product recall(1)

-

-

-

300

1,530

1,830

Coolers & Equipment adjusted net sales

$ 156,101

$ 232,404

$ 388,505

$ 156,401

$ 233,934

$ 390,335

United States net sales

$ 293,086

$ 390,965

$ 684,051

$ 293,086

$ 390,965

$ 684,051

Product recall(1)

-

-

-

300

1,530

1,830

United States adjusted net sales

$ 293,086

$ 390,965

$ 684,051

$ 293,386

$ 392,495

$ 685,881

YETI Holdings, Inc.

Recast of Non-GAAP Financial Results (In thousands) (Unaudited)

As Reported

As Recast

Q1'25

Q2'25

Q3'25

Q4'25

FY25

Q1'25

Q2'25

Q3'25

Q4'25

FY25

Net sales

$ 351,128

$ 445,892

$ 487,766

$ 583,708

$1,868,494

$ 351,128

$ 445,892

$ 487,766

$ 583,708

$1,868,494

Product recall(1)

-

-

-

-

-

-

-

-

2,275

2,275

Adjusted net sales

$ 351,128

$ 445,892

$ 487,766

$ 583,708

$1,868,494

$ 351,128

$ 445,892

$ 487,766

$ 585,983

$1,870,769

Direct-to-consumer net sales

$ 196,216

$ 248,596

$ 288,719

$ 394,260

$1,127,791

$ 196,216

$ 248,596

$ 288,719

$ 394,260

$1,127,791

Product recall(1)

-

-

-

-

-

-

-

-

2,275

2,275

Direct-to-consumer adjusted net sales

$ 196,216

$ 248,596

$ 288,719

$ 394,260

$1,127,791

$ 196,216

$ 248,596

$ 288,719

$ 396,535

$1,130,066

Coolers & Equipment net sales $ 140,217

$ 200,572

$ 215,386

$ 192,348

$ 748,523

$ 140,217

$ 200,572

$ 215,386

$ 192,348

$ 748,523

Product recall(1) -

-

-

-

-

-

-

-

2,275

2,275

Coolers & Equipment adjusted net sales $ 140,217

$ 200,572

$ 215,386

$ 192,348

$ 748,523

$ 140,217

$ 200,572

$ 215,386

$ 194,623

$ 750,798

United States net sales $ 271,275

$ 367,772

$ 387,329

$ 447,765

$1,474,141

$ 271,275

$ 367,772

$ 387,329

$ 447,765

$1,474,141

Product recall(1) -

-

-

-

-

-

-

-

2,275

2,275

United States adjusted net sales $ 271,275

$ 367,772

$ 387,329

$ 447,765

$1,474,141

$ 271,275

$ 367,772

$ 387,329

$ 450,040

$1,476,416

(1) Represents adjustments and charges associated with our 2023 product recalls.

Non-GAAP Financial Measures

In addition to our results determined in accordance with GAAP, we supplement our results with non-GAAP financial measures, including adjusted net sales, adjusted gross profit, adjusted gross margin, adjusted SG&A expenses, adjusted operating income, adjusted net income, adjusted net income per diluted share (which we also refer to as adjusted EPS), free cash flow as well as adjusted gross profit, adjusted SG&A expenses, adjusted operating income and adjusted net income as a percentage of adjusted net sales.

Our management uses these non-GAAP financial measures in conjunction with GAAP financial measures to measure our profitability and to evaluate our financial performance. We believe that these non-GAAP financial measures provide meaningful supplemental information regarding the underlying operating performance of our business and are appropriate to enhance an overall understanding of our financial performance. These non-GAAP financial measures have limitations as analytical tools in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP. Because of these limitations, these non-GAAP financial measures should be considered along with GAAP financial performance measures. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for, or superior to, financial information prepared and presented in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures. A reconciliation of the non-GAAP financial measures to such GAAP measures can be found above.

YETI Holdings, Inc. on 6ix

Earlier from YETI

Later from YETI

All YETI news releases